Gameday Men's Health Mont Belvieu, TX
Gameday Men's Health Mont Belvieu, TX · 9737 Eagle Drive · Mont Belvieu, TX 77523
5.0· 148 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- GLP-1 medications named on site
- Medically supervised weight loss
- Endocrine / metabolic care
About this practice
Gameday Men's Health is a clinic for men's health in Mont Belvieu, Texas, with weight-management and hormone services among its offerings. According to its website, the Mont Belvieu clinic is among more than 400 nationwide that focus on men, with private rooms and an emphasis on optimization. Services in Mont Belvieu include GLP-1 therapy (semaglutide and tirzepatide), which its website ties to appetite regulation and blood sugar control, along with MIC B12 injections. Telehealth visits are available for Mont Belvieu patients. On Google, the Mont Belvieu clinic holds a 5.0-star rating across 148 reviews, with 28 posted in the past year; reviewers most often bring up the staff and the team's knowledge.
Services & access
| Advertises semaglutide today | Yes |
| Advertises tirzepatide today | Yes |
| Telehealth visits | Yes |
| Cash pay accepted | Yes |
| Accepts insurance — per practice website | Not listed |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-08-10. Read the reviews themselves on the practice's Google listing.
What patients say
This practice holds a ★5.0 Google rating across 148 reviews. 96% of the 28 reviews we analyzed are 5-star. reviewers most often mention staff & front desk (11), professionalism & expertise (5), results (2), feeling listened to (1).
Most recent Google reviews
Robert M.★★★★★2026-08-10Great service
Quenton C.★★★★★2026-08-07Very nice customer service
Andy N.★★★★★2026-07-10Best place ever.
Joel M.★★★★★2026-06-15Very clean establishment. The staff is very nice . Easy process to get started
Salvador H.★★★★★2026-05-06Great service amazing staff
Reviews and counts are from this practice's public Google Business listing and reflect their authors' opinions, not RetaMaps'. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs